|
|||||
|
|
Multidrug resistance associated with altered topoisomerase II activity--topoisomerases II as targets for rational drug design |
|
| Authors: | C S Morrow K H Cowan |
| Affiliation: | Medicine Branch, National Cancer Institute, Bethesda, MD 20892. |
| Abstract: | |
| Keywords: | |